Pancreatic Adenocarcinoma Treatment Market Trends
Growth Drivers
- Increasing Prevalence of Pancreatic Disorders owing to Germline Mutations – In the U.S. more than 60,000 people are diagnosed with pancreatic cancer as of 2023.
- Rising Geriatric Population across the World with Reduced Immunity – As per the estimations in 2023, more than 1 in 6 people in America which is 80 million people are now the age 65 and above.
- Increasing Incidence of Cancers related to the Digestive System and Stomach owing to Unhealthy Foods – The number of cancer cases reported in the year 2019 across the U.S. was over 1,752,700 and 600,000 people died from cancer.
- Increasing use of Chemotherapy and Radiotherapy Treatments around the Globe – More than 50% of cancer patients are estimated to receive radiation therapy as of 2023 estimations.
- Rising Healthcare Expenditure with Improved Infrastructure Facilities – The healthcare expenditure of the U.S. was estimated to increase by more than 25% in the year 2021 with a value of over USD 4 trillion.
Challenges
- Rising Cost of Drug Development and Treatment
- Side Effects of Radiation and Chemotherapy –
The side effects of chemotherapy include pain, dizziness, fever, vomiting, and frequent bowel movement and the side effects of radiation therapy include diarrhea, shortness of breath, change in taste, and urinary and bladder problems. All these factors are estimated to be the reason for the hampering of market growth.
- Stringent Government Regulatory Guidelines
Pancreatic Adenocarcinoma Treatment Market: Key Insights
According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
14.3% |
|
Base Year Market Size (2024) |
USD 2.62 billion |
|
Forecast Year Market Size (2037) |
USD 14.89 billion |
|
Regional Scope |
|
